SC refers 349 FDC medicines to Drug Advisory Board for relook

A bench said that the 349 FDCs were banned pursuant to the Kokate Committee report, by notifications of the central government under Section 26A of the Drugs Act.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news